Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospectively Randomized Study of Intraovarian Injections of Autologous Platelet-rich Plasma (PRP) in Women With Primary Ovarian Insufficiency (POI)

NCT03542708 is registered in ClinicalTrials.gov with Center for Human Reproduction as lead sponsor.

NCT NCT03542708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospectively Randomized Study of Intraovarian Injections of Autologous Platelet-rich Plasma (PRP) in Women With Primary Ovarian Insufficiency (POI)
Lead sponsor
Center for Human Reproduction
Phase
Not applicable
Overall status
Completed
Start date
July 25, 2018
Completion date
April 1, 2024
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature menopause, primary ovarian insufficiency